Until the end of your next turn, if an attack damages the Defending Pokémon (after applying Weakness and Resistance), that attack does 20 more damage to the Defending Pokémon.
If this attack damages the Defending Pokémon, the Defending Pokémon is now Poisoned and you remove a number of damage counters from Golbat equal to half that damage (rounded up to the nearest 10). If Golbat has fewer damage counters than that, remove all of them. Either way, the Defending Pokémon is now Poisoned.
Neo Revelation entered circulation in 2001. It belongs to the Neo series.
The checklist contains 66 cards, placing it in a compact expansion range. As of 2026, the set is 25 years old and fits a legacy-era profile.
Golbat (#29) is one of the Uncommon prints in this expansion.
Golbat is a Neo Revelation card from the 2001 release window. The printed flavor text states: "It can drink more than 10 ounces of blood at once.
If it has too much, it gets heavy and flies clumsily." Core profile: Its card type is Pokémon. The rarity label is Uncommon.
Printed HP is 60. Energy typing is Grass.
Golbat evolves from Zubat. The printed attacks highlight "Screech" and "Poison Bite".
Current market pricing for Golbat (Neo Revelation) sits near $2.64. Price action is stable over 7 days, moving only 0.0%.
Relative to the last 30 days, value is near baseline at $2.63. Its 90-day trading band runs between $2.25 and $2.67, producing a 16% range and low-volatility behavior.
This version is categorized as Uncommon.
Golbat sits within a broader pool of Golbat variants that can be compared by set, rarity, and price. The current sample spans 6 comparable cards from 6 sets.
Observed alternatives run from $0.08 to $0.24 (200% spread). The current card sits +2012% versus the sampled alternative average of $0.13.
Notable alternatives include Golbat #32 (Phantom Forces) at $0.24, Golbat #90 (Battle Styles) at $0.10, Golbat #104 (Silver Tempest) at $0.08, and Golbat #28 (Shrouded Fable) at $0.08.
Current valuation lens: We observe a 0.0% shift this week, which points toward price consolidation rather than immediate volatility. Observed 90-day bounds of $2.25 and $2.67 create a 16% band, matching a low-volatility profile.
Current value remains close to its 30-day mean ($2.63). Graded context points to a substantial premium curve, with PSA 10 at +3106% above raw pricing.
PSA 9 is currently around $36.00, while PSA 10 is $84.64.
